Exploring the biology of cancer of unknown primary: breakthroughs and drawbacks

Intracellular signalling via the AKT axis and downstream effectors is active and prognostically significant in cancer of unknown primary (CUP): a study of 100 CUP cases

(2012) V. Golfinopoulos et al.   ANNALS OF ONCOLOGY

Profiling immunohistochemical expression of NOTCH1–3, JAGGED1, cMET, and phospho-MAPK in 100 carcinomas of unknown primary

(2012) Dimitrios Krikelis et al.   CLINICAL & EXPERIMENTAL METASTASIS

Targeting the PI3K signaling pathway in cancer therapy

(2012) Chandra Bartholomeusz et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Molecular Gene Expression Profiling to Predict the Tissue of Origin and Direct Site-Specific Therapy in Patients With Carcinoma of Unknown Primary Site: A Prospective Trial of the Sarah Cannon Research Institute

(2012) John D. Hainsworth et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer of unknown primary site

(2012) Nicholas Pavlidis et al.   LANCET

MET: a promising anticancer therapeutic target

(2012) Solange Peters et al.   Nature Reviews Clinical Oncology

Cancer stem cells and metastasis

(2012) Katia Sampieri et al.   SEMINARS IN CANCER BIOLOGY

Angiogenic ability of metastatic squamous carcinoma in the cervical lymph nodes from unknown primary tumours

(2011) B. Agarwal et al.   JOURNAL OF CLINICAL PATHOLOGY

Hypoxia-related protein expression and its clinicopathologic implication in carcinoma of unknown primary

(2011) Ja Seung Koo et al.   TUMOR BIOLOGY

Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis

(2010) X. Lu et al.   CLINICAL CANCER RESEARCH

MET mutations in cancers of unknown primary origin (CUPs)

(2010) Giulia M. Stella et al.   HUMAN MUTATION

Epithelial-mesenchymal transition in cancer development and its clinical significance

(2009) Masaaki Iwatsuki et al.   CANCER SCIENCE

Paclitaxel/Carboplatin plus Bevacizumab/Erlotinib in the First-Line Treatment of Patients with Carcinoma of Unknown Primary Site

(2009) J. D. Hainsworth et al.   ONCOLOGIST

Systemic Dissemination in Cancer of Unknown Primary is Independent of Mutational Inactivation of the KiSS-1 Metastasis-suppressor Gene

(2009) L. Dova et al.   PATHOLOGY & ONCOLOGY RESEARCH

The kisspeptin (KiSS-1)/GPR54 system in cancer biology

(2008) Angeliki Makri et al.   CANCER TREATMENT REVIEWS

Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: A systematic literature review

(2008) George Pentheroudakis et al.   CANCER TREATMENT REVIEWS

Platinum Resistance: The Role of DNA Repair Pathways

(2008) L. P. Martin et al.   CLINICAL CANCER RESEARCH

Carcinoma of unknown primary (CUP)

(2008) Nicholas Pavlidis et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Molecular evidence for a clonal relationship between multiple lesions in patients with unknown primary adenocarcinoma

(2008) Ernst‐Jan M. Speel et al.   INTERNATIONAL JOURNAL OF CANCER